Flamma Group
Andrea Doria has extensive experience in Quality Assurance and Quality Control within the pharmaceutical industry. Currently serving as the Quality Unit Director and Qualified Person at Flamma Group since May 2022, Andrea oversees the Quality Unit at the Isso manufacturing site. Previous positions include Quality Assurance Manager and Qualified Person at Lusochimica S.p.A. from September 2016 to April 2022, and Quality Assurance Manager at ACS DOBFAR from April 2009 to September 2016, where responsibilities included managing the Quality Assurance department and handling regulatory compliance. Andrea’s career began in manufacturing process development at Fresenius Kabi from October 2007 to March 2009. Andrea holds a degree in Medicinal and Pharmaceutical Chemistry from the University of Padova, graduated in 2005.
This person is not in any offices
Flamma Group
FLAMMA is a family owned & run, award winning, fully integrated CDMO with Headquarters located near Milan, Italy. FLAMMA specializes in the cGMP manufacturing of small molecule APIs, NCEs, RSMs & advanced intermediates. FLAMMA has significant expertise in high value chiral materials (specifically amino acid related materials used in peptide drugs). FLAMMA provides manufacturing options for the entire life cycle of a small molecule drug. FLAMMA can provide assistance for early stage pre-clinical development (from g to kg using our facility located outside of Philadelphia in the USA) to large-scale commercial manufacturing (from 100’s of kg to MT) at one of our three facilities located in Italy. FLAMMA’s 100% owned and self-managed facility in Dalian, China allows one to leverage its offerings to provide a stable and secure supply chain. With over 800 employees and a total capacity of 1,100 m3 (900 m3 in Italy and 200 m3 in China), learn why FLAMMA is a preferred supplier to the pharmaceutical and biotech industry. Follow Us! FLAMMA- The Thinking CDMO™ http://www.flammagroup.com